Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach (English)
- New search for: Senna, J. P.
- New search for: Roth, D. M.
- New search for: Oliveira, J. S.
- New search for: Machado, D. C.
- New search for: Santos, D. S.
- New search for: Senna, J. P.
- New search for: Roth, D. M.
- New search for: Oliveira, J. S.
- New search for: Machado, D. C.
- New search for: Santos, D. S.
In:
VACCINE -GUILDFORD THEN LONDON THEN OXFORD-
;
21
, 19-20
;
2661-2666
;
2003
-
ISSN:
- Article (Journal) / Print
-
Title:Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach
-
Contributors:Senna, J. P. ( author ) / Roth, D. M. ( author ) / Oliveira, J. S. ( author ) / Machado, D. C. ( author ) / Santos, D. S. ( author )
-
Published in:VACCINE -GUILDFORD THEN LONDON THEN OXFORD- ; 21, 19-20 ; 2661-2666
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2003-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 615.372
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 615.372 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 21, Issue 19-20
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2223
-
The use of hepatitis A vaccine in Italy-evidence-based recommendations from an expert panelMele, A. / Jefferson, T. et al. | 2003
- 2224
-
Risk groups for hepatitis A virus infectionFranco, E. / Giambi, C. / Ialacci, R. / Coppola, R. C. / Zanetti, A. R. et al. | 2003
- 2234
-
Hepatitis A: post-exposure prophylaxisTaliani, G. / Gaeta, G. B. et al. | 2003
- 2238
-
HAV infection in chronic liver disease: a rationale for vaccinationAlmasio, P. L. / Amoroso, P. et al. | 2003
- 2242
-
The effectiveness and safety of hepatitis A vaccine: a systematic reviewDemicheli, V. / Tiberti, D. et al. | 2003
- 2246
-
The role of vaccine in controlling hepatitis A epidemicsD'Argenio, P. / Adamo, B. / Cirrincione, R. / Gallo, G. et al. | 2003
- 2250
-
The use of hepatitis a vaccination in Italy: an economic evaluationDemicheli, V. / Carniglia, E. / Fucci, S. et al. | 2003
- 2258
-
Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDSFincham, J. E. / Markus, M. B. / Adams, V. J. et al. | 2003
- 2260
-
Comments on the paper "The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data" [P. Rivest, R. Allard, Vaccine 20 (2002) 2533-2536]De Wals, P. / De Serres, G. et al. | 2003
- 2262
-
Reply to the letter of Drs De Wals and De SerresAllard, R. / Rivest, P. et al. | 2003
- 2263
-
Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsidsRollman, E. / Ramqvist, T. / Zuber, B. / Tegerstedt, K. / Kjerrstrom Zuber, A. / Klingstrom, J. / Eriksson, L. / Ljungberg, K. / Hinkula, J. / Wahren, B. et al. | 2003
- 2268
-
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activationBrandao, J. G. / Scheper, R. J. / Lougheed, S. M. / Curiel, D. T. / Tillman, B. W. / Gerritsen, W. R. / van den Eertwegh, A. J. / Pinedo, H. M. / Haisma, H. J. / de Gruijl, T. D. et al. | 2003
- 2273
-
Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learnedCapiau, C. / Poolman, J. / Hoet, B. / Bogaerts, H. / Andre, F. et al. | 2003
- 2288
-
Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA primingWang, X. / Wiley, R. D. / Evans, T. G. / Bowers, W. J. / Federoff, H. J. / Dewhurst, S. et al. | 2003
- 2298
-
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccineHalperin, S. A. / Scheifele, D. / Mills, E. / Guasparini, R. / Humphreys, G. / Barreto, L. / Smith, B. et al. | 2003
- 2307
-
Gene expression after vaccination of mice with formulations of diphtheria toxoid or tetanus toxoid and different adjuvants: identification of shared and vaccine-specific genes in spleen lymphocytesRegnstrom, K. / Ragnarsson, E. / Artursson, P. et al. | 2003
- 2318
-
Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2)Nguyen, C. L. / Salem, M. L. / Rubinstein, M. P. / Demcheva, M. / Vournakis, J. N. / Cole, D. J. / Gillanders, W. E. et al. | 2003
- 2329
-
Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicityFowler, S. / Xing, D. K. / Bolgiano, B. / Yuen, C. T. / Corbel, M. J. et al. | 2003
- 2338
-
Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeysTanabayashi, K. / Mukai, R. / Yamada, A. / Takasaki, T. / Kurane, I. / Yamaoka, M. / Terazawa, A. / Konishi, E. et al. | 2003
- 2346
-
Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccineDe Serres, G. / Boulianne, N. / Duval, B. / Rochette, L. / Grenier, J. L. / Roussel, R. / Donaldson, D. / Tremblay, M. / Toth, E. / Menard, S. et al. | 2003
- 2354
-
The clinical spectrum of the oculo-respiratory syndrome after influenza vaccinationDe Serres, G. / Grenier, J. L. / Toth, E. / Menard, S. / Roussel, R. / Tremblay, M. / Fradet, M. D. / Landry, M. / Robert, Y. / Skowronski, D. M. et al. | 2003
- 2362
-
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumoniaIto, R. / Ozaki, Y. A. / Yoshikawa, T. / Hasegawa, H. / Sato, Y. / Suzuki, Y. / Inoue, R. / Morishima, T. / Kondo, N. / Sata, T. et al. | 2003
- 2372
-
Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complexShkreta, L. / Talbot, B. G. / Lacasse, P. et al. | 2003
- 2383
-
Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell responseSyed, F. M. / Khan, M. A. / Nasti, T. H. / Ahmad, N. / Mohammad, O. et al. | 2003
- 2394
-
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of ageQadri, F. / Ahmed, T. / Ahmed, F. / Bradley Sack, R. / Sack, D. A. / Svennerholm, A. M. et al. | 2003
- 2404
-
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP)Lopez, R. / Garcia, J. / Puentes, A. / Curtidor, H. / Ocampo, M. / Vera, R. / Rodriguez, L. E. / Suarez, J. / Urquiza, M. / Rodriguez, A. L. et al. | 2003
- 2412
-
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Van der Wielen, M. / Van Damme, P. / Van Herck, K. / Schlegel-Haueter, S. / Siegrist, C. A. et al. | 2003
- 2418
-
Effect of Vitamin A supplementation on the immune response to measles vaccinationCherian, T. / Varkki, S. / Raghupathy, P. / Ratnam, S. / Chandra, R. K. et al. | 2003
- 2421
-
Why do older people not get immunised against influenza?Evans, M. R. / Watson, P. A. et al. | 2003
- 2428
-
The association between psychosocial factors and vaccine-induced cytokine productionHayney, M. S. / Love, G. D. / Buck, J. M. / Ryff, C. D. / Singer, B. / Muller, D. et al. | 2003
- 2433
-
Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1Martina, B. E. / van de Bildt, M. W. / Kuiken, T. / van Amerongen, G. / Osterhaus, A. D. et al. | 2003
- 2441
-
Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus constructNicholas, B. L. / Brennan, F. R. / Hamilton, W. D. / Wakelin, D. et al. | 2003
- 2448
-
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosisPiedra, P. A. / Cron, S. G. / Jewell, A. / Hamblett, N. / McBride, R. / Palacio, M. A. / Ginsberg, R. / Oermann, C. M. / Hiatt, P. W. et al. | 2003
- 2461
-
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvantHalperin, S. A. / Van Nest, G. / Smith, B. / Abtahi, S. / Whiley, H. / Eiden, J. J. et al. | 2003
- 2468
-
Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?Clarke, S. C. / Diggle, M. A. / Molling, P. / Unemo, M. / Olcen, P. et al. | 2003
- 2474
-
Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK.Ramiro, M. J. / Zarate, J. J. / Hanke, T. / Rodriguez, D. / Rodriguez, J. R. / Esteban, M. / Lucientes, J. / Castillo, J. A. / Larraga, V. et al. | 2003
- 2485
-
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium bergheiMeraldi, V. / Audran, R. / Romero, J. F. / Brossard, V. / Bauer, J. / Lopez, J. A. / Corradin, G. et al. | 2003
- 2492
-
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal micePihlgren, M. / Tougne, C. / Schallert, N. / Bozzotti, P. / Lambert, P. H. / Siegrist, C. A. et al. | 2003
- 2500
-
A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV)Huang, Y. / Anderson, R. et al. | 2003
- 2506
-
Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviationKotecha, M. T. / Afghan, R. K. / Vasilikopoulou, E. / Wilson, E. / Marsh, P. / Kast, W. M. / Davies, D. H. / Caparros-Wanderley, W. et al. | 2003
- 2516
-
The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticityWu, S. C. / Yu, C. H. / Lin, C. W. / Chu, I. M. et al. | 2003
- 2523
-
Antibody response to vaccination and psychosocial stress in humans: relationships and mechanismsBurns, V. E. / Carroll, D. / Ring, C. / Drayson, M. et al. | 2003
- 2535
-
Three types of immunotherapics against pythiosis insidiosi developed and evaluatedSanturio, J. M. / Leal, A. T. / Leal, A. B. / Festugatto, R. / Lubeck, I. / Sallis, E. S. / Copetti, M. V. / Alves, S. H. / Ferreiro, L. et al. | 2003
- 2541
-
The incidence of shingles and its implications for vaccination policyChapman, R. S. / Cross, K. W. / Fleming, D. M. et al. | 2003
- 2548
-
Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6de Lorimier, A. J. / Byrd, W. / Hall, E. R. / Vaughan, W. M. / Tang, D. / Roberts, Z. J. / McQueen, C. E. / Cassels, F. J. et al. | 2003
- 2556
-
Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigsVerheije, M. H. / Kroese, M. V. / van der Linden, I. F. / de Boer-Luijtze, E. A. / van Rijn, P. A. / Pol, J. M. / Meulenberg, J. J. / Steverink, P. J. et al. | 2003
- 2564
-
The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccineMcIntosh, E. D. / Conway, P. / Willingham, J. / Lloyd, A. et al. | 2003
- 2573
-
Effect of infant immunisation with meningococcus serogroup C-CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged childrenMcVernon, J. / MacLennan, J. / Clutterbuck, E. / Buttery, J. / Moxon, E. R. et al. | 2003
- 2580
-
The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school childrenRager-Zisman, B. / Bazarsky, E. / Skibin, A. / Chamney, S. / Belmaker, I. / Shai, I. / Kordysh, E. / Griffin, D. E. et al. | 2003
- 2589
-
IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosisde Oliveira Mendes, C. / Paraguai de Souza, E. / Borja-Cabrera, G. P. / Maria Melo Batista, L. / Aparecida dos Santos, M. / Ellner Parra, L. / Menz, I. / Palatnik, M. / Palatnik de Sousa, C. B. et al. | 2003
- 2598
-
A comparison of DNA vaccines for the rabies-related virus, MokolaNel, L. H. / Niezgoda, M. / Hanlon, C. A. / Morril, P. A. / Yager, P. A. / Rupprecht, C. E. et al. | 2003
- 2607
-
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccinePurcell, R. H. / Nguyen, H. / Shapiro, M. / Engle, R. E. / Govindarajan, S. / Blackwelder, W. C. / Wong, D. C. / Prieels, J. P. / Emerson, S. U. et al. | 2003
- 2616
-
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2Mozdzanowska, K. / Feng, J. / Eid, M. / Kragol, G. / Cudic, M. / Otvos Jr, L. / Gerhard, W. et al. | 2003
- 2627
-
Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infantsYeh, S. H. / Zangwill, K. M. / Lee, H. / Chang, S. J. / Wong, V. I. / Greenberg, D. P. / Ward, J. I. et al. | 2003
- 2632
-
Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunityShanley, J. D. / Wu, C. A. et al. | 2003
- 2643
-
Reconstruction of measles dynamics in a vaccinated populationWallinga, J. / Teunis, P. / Kretzschmar, M. et al. | 2003
- 2651
-
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidatePlotnicky, H. / Siegrist, C. A. / Aubry, J. P. / Bonnefoy, J. Y. / Corvaia, N. / Nguyen, T. N. / Power, U. F. et al. | 2003
- 2661
-
Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approachSenna, J. P. / Roth, D. M. / Oliveira, J. S. / Machado, D. C. / Santos, D. S. et al. | 2003
- 2667
-
Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in miceScappaticci, F. A. / Contreras, A. / Boswell, C. A. / Lewis, J. S. / Nolan, G. et al. | 2003
- 2678
-
Novel configurations of high molecular weight species of the pertussis toxin vaccine componentFowler, S. / Byron, O. / Jumel, K. / Xing, D. / Corbel, M. J. / Bolgiano, B. et al. | 2003
- 2689
-
Erratum to "Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum" [Vaccine 21 (2003) 269-280]Edelman, R. / Wasserman, S. S. / Kublin, J. G. / Bodison, S. A. / Nardin, E. H. / Oliveira, G. A. / Ansari, S. / Diggs, C. L. / Kashala, O. L. / Schrneckpeper, B. J. et al. | 2003
- 2690
-
Biodefense Vaccines, Therapeutics and Diagnostics: Policy, Funding, Development, Testing, Production, and Distribution Conference, June 2-4, 2003, Washington, DC| 2003
-
Editorial Board| 2003